Literature DB >> 6280320

Neurotoxicity of antineoplastic drugs.

R S Kaplan, P H Wiernik.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1982        PMID： 6280320

Source DB:  PubMed          Journal:  Semin Oncol        ISSN： 0093-7754            Impact factor:   4.929


× No keyword cloud information.
  35 in total

Review 1.  Intrathecal chemotherapy with antineoplastic agents in children.

Authors:  A Ruggiero; V Conter; M Milani; E Biagi; I Lazzareschi; P Sparano; R Riccardi
Journal:  Paediatr Drugs       Date:  2001       Impact factor: 3.022

2.  A phase I trial of 5-fluorouracil, leucovorin, and dipyridamole given by concurrent 120-h continuous infusions.

Authors:  H Bailey; G Wilding; K D Tutsch; R Z Arzoomanian; D Alberti; M B Tombes; J L Grem; D R Spriggs
Journal:  Cancer Chemother Pharmacol       Date:  1992       Impact factor: 3.333

Review 3.  Do anticancer agents reach the tumor target in the human brain?

Authors:  M G Donelli; M Zucchetti; M D'Incalci
Journal:  Cancer Chemother Pharmacol       Date:  1992       Impact factor: 3.333

Review 4.  Minimising the side effects of cancer chemotherapy in senior patients.

Authors:  T Kinzel; V Feleppa
Journal:  Drugs Aging       Date:  1992 Mar-Apr       Impact factor: 3.923

Review 5.  Antineoplastic drugs in 1990. A review (Part II).

Authors:  D J Black; R B Livingston
Journal:  Drugs       Date:  1990-05       Impact factor: 9.546

6.  Substantial excretion of digoxin via the intestinal mucosa and prevention of long-term digoxin accumulation in the brain by the mdr 1a P-glycoprotein.

Authors:  U Mayer; E Wagenaar; J H Beijnen; J W Smit; D K Meijer; J van Asperen; P Borst; A H Schinkel
Journal:  Br J Pharmacol       Date:  1996-11       Impact factor: 8.739

7.  Peripheral DTIC neurotoxicity: a case report.

Authors:  M Amichetti; S Piffer; R Valdagni; G Ambrosini; M Piazza
Journal:  Cancer Chemother Pharmacol       Date:  1987       Impact factor: 3.333

8.  Cardiovascular autonomic function in anthracycline-treated breast cancer patients.

Authors:  M Viniegra; M Marchetti; M Losso; A Navigante; S Litovska; A Senderowicz; L Borghi; J Lebron; D Pujato; H Marrero
Journal:  Cancer Chemother Pharmacol       Date:  1990       Impact factor: 3.333

9.  Clinical trial of pyridoxine to reduce vincristine neurotoxicity.

Authors:  D V Jackson; E K Pope; R A McMahan; M R Cooper; J N Atkins; R D Callahan; E H Paschold; R A Grimm; J O Hopkins; H B Muss
Journal:  J Neurooncol       Date:  1986       Impact factor: 4.130

10.  Brain uptake and anticancer activities of vincristine and vinblastine are restricted by their low cerebrovascular permeability and binding to plasma constituents in rat.

Authors:  N H Greig; T T Soncrant; H U Shetty; S Momma; Q R Smith; S I Rapoport
Journal:  Cancer Chemother Pharmacol       Date:  1990       Impact factor: 3.333
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.